Literature DB >> 19960452

Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains.

Jan Pruszak1, Lothar Just, Ole Isacson, Guido Nikkhah.   

Abstract

The ability to isolate ventral midbrain (VM) precursor cells and neurons provides a powerful means to characterize their differentiation properties and to study their potential for restoring dopamine (DA) neurons degenerated in Parkinson's disease (PD). Preparation and maintenance of DA VM in primary culture involves a number of critical steps to yield healthy cells and appropriate data. Here, we offer a detailed description of protocols to consistently prepare VM DA cultures from rat and mouse embryonic fetal-stage midbrain. We also present methods for organotypic culture of midbrain tissue, for differentiation as aggregate cultures, and for adherent culture systems of DA differentiation and maturation, followed by a synopsis of relevant analytical read-out options. Isolation and culture of rodent VM precursor cells and DA neurons can be exploited for studies of DA lineage development, of neuroprotection, and of cell therapeutic approaches in animal models of PD. Copyright 2009 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960452     DOI: 10.1002/9780470151808.sc02d05s11

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  25 in total

1.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

2.  Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Authors:  Patricia Del Cerro; Carolina Alquézar; Fernando Bartolomé; Pedro González-Naranjo; Concepción Pérez; Eva Carro; Juan A Páez; Nuria E Campillo; Ángeles Martín-Requero
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

3.  Pharmacologically increasing microtubule acetylation corrects stress-exacerbated effects of organophosphates on neurons.

Authors:  Anand N Rao; Ankita Patil; Zachary D Brodnik; Liang Qiang; Rodrigo A España; Kimberly A Sullivan; Mark M Black; Peter W Baas
Journal:  Traffic       Date:  2017-05-25       Impact factor: 6.215

4.  Incubator embedded cell culture imaging system (EmSight) based on Fourier ptychographic microscopy.

Authors:  Jinho Kim; Beverley M Henley; Charlene H Kim; Henry A Lester; Changhuei Yang
Journal:  Biomed Opt Express       Date:  2016-07-22       Impact factor: 3.732

5.  Flow cytometry protocols for surface and intracellular antigen analyses of neural cell types.

Authors:  Vishal Menon; Ria Thomas; Arun R Ghale; Christina Reinhard; Jan Pruszak
Journal:  J Vis Exp       Date:  2014-12-18       Impact factor: 1.355

6.  Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.

Authors:  Ariadna Laguna; Nicoletta Schintu; André Nobre; Alexandra Alvarsson; Nikolaos Volakakis; Jesper Kjaer Jacobsen; Marta Gómez-Galán; Elena Sopova; Eliza Joodmardi; Takashi Yoshitake; Qiaolin Deng; Jan Kehr; Johan Ericson; Per Svenningsson; Oleg Shupliakov; Thomas Perlmann
Journal:  Nat Neurosci       Date:  2015-04-27       Impact factor: 24.884

7.  Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons.

Authors:  Miriam Sciaccaluga; Claudia Moriconi; Katiuscia Martinello; Myriam Catalano; Isabel Bermudez; Jerry A Stitzel; Uwe Maskos; Sergio Fucile
Journal:  FASEB J       Date:  2015-04-24       Impact factor: 5.191

8.  Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.

Authors:  C Zhang; Y Jin; K S Ziemba; A M Fletcher; B Ghosh; E Truit; D M Yurek; G M Smith
Journal:  Exp Neurol       Date:  2013-10-04       Impact factor: 5.330

9.  Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2015-10-01       Impact factor: 5.695

10.  Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease.

Authors:  Laura A Struzyna; Kevin D Browne; Zachary D Brodnik; Justin C Burrell; James P Harris; H Isaac Chen; John A Wolf; Kate V Panzer; James Lim; John E Duda; Rodrigo A España; D Kacy Cullen
Journal:  J Tissue Eng Regen Med       Date:  2018-06-03       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.